Drugs / ACAM FLU-A
last change Feb 2009 re-read 3 minutes ago

ACAM FLU-A

Developed for
influenza
Investigated by
Sanofi

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00819013 Jul 2007 → Jan 2009 influenza Sanofi Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ACAM FLU-A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00819013 ↗
Route Intramuscular “0.5 mL ACAM-FLU-A low dose + Adjuvant 1, Intramuscular” NCT00819013 ↗